Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Cervantes

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Diseases of the Colon and Rectum|January 10, 2012
Pathological evaluation of mesocolic resection quality and ex vivo methylene blue injection: what is the impact on lymph node harvest after colon resection for cancer?Matteo Frasson, Carmen Faus, Alvaro Garcia-Granero, et al.
Diseases of the Colon and Rectum|May 7, 2015
Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessaryFranco G Marinello, Matteo Frasson, Gloria Baguena, et al.
Cancers|April 25, 2020
Personalized Medicine: Recent Progress in Cancer TherapyValentina Gambardella, Noelia Tarazona, Juan Miguel Cejalvo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 26, 2015
Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of lifeLori Brotto, Michael Brundage, Paul Hoskins, et al.
Cancer Treatment Reviews|March 17, 2023
European expert panel consensus on the clinical management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancerErika Martinelli, Dirk Arnold, Andres Cervantes, et al.
Journal of Clinical Pharmacology|May 20, 2011
Evaluation of the quality of publications on randomized clinical trials using the Consolidated Standards of Reporting Trials (CONSORT) statement guidelines in a Spanish tertiary hospitalFrancisco Dasí, María Mercedes Navarro-García, Mercedes Jiménez-Heredia, et al.
Future Oncology (London, England)|June 11, 2024
Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidenceAndres Cervantes, Josep Tabernero, Rocio Garcia-Carbonero, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 15, 2023
The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancerJorge Sancho-Muriel, Francisco Giner, Hanna Cholewa, et al.
Cancer Chemotherapy and Pharmacology|September 2, 2021
Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertibVikram Malhi, Nageshwar Budha, Rucha Sane, et al.
Histopathology|May 14, 2019
Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimensCarolina Martinez-Ciarpaglini, Carlos Fernandez-Sellers, Noelia Tarazona, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Diseases of the Colon and Rectum|January 10, 2012
Pathological evaluation of mesocolic resection quality and ex vivo methylene blue injection: what is the impact on lymph node harvest after colon resection for cancer?Matteo Frasson, Carmen Faus, Alvaro Garcia-Granero, et al.
Diseases of the Colon and Rectum|May 7, 2015
Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessaryFranco G Marinello, Matteo Frasson, Gloria Baguena, et al.
Cancers|April 25, 2020
Personalized Medicine: Recent Progress in Cancer TherapyValentina Gambardella, Noelia Tarazona, Juan Miguel Cejalvo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 26, 2015
Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of lifeLori Brotto, Michael Brundage, Paul Hoskins, et al.
Cancer Treatment Reviews|March 17, 2023
European expert panel consensus on the clinical management of BRAF<sup>V600E</sup>-mutant metastatic colorectal cancerErika Martinelli, Dirk Arnold, Andres Cervantes, et al.
Journal of Clinical Pharmacology|May 20, 2011
Evaluation of the quality of publications on randomized clinical trials using the Consolidated Standards of Reporting Trials (CONSORT) statement guidelines in a Spanish tertiary hospitalFrancisco Dasí, María Mercedes Navarro-García, Mercedes Jiménez-Heredia, et al.
Future Oncology (London, England)|June 11, 2024
Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidenceAndres Cervantes, Josep Tabernero, Rocio Garcia-Carbonero, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 15, 2023
The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancerJorge Sancho-Muriel, Francisco Giner, Hanna Cholewa, et al.
Cancer Chemotherapy and Pharmacology|September 2, 2021
Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertibVikram Malhi, Nageshwar Budha, Rucha Sane, et al.
Histopathology|May 14, 2019
Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimensCarolina Martinez-Ciarpaglini, Carlos Fernandez-Sellers, Noelia Tarazona, et al.
Pageof 8